MIR548AP

Across TCGA pan-cancer cohorts, MIR548AP RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated MIR548AP data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher MIR548AP RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR548AP expression acts as an unfavorable survival marker.

OV, LIHC, and SKCM are the cancer types where MIR548AP RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	OS	Tertile	II,III,IV	0.022	0.844	<.001	144	view →
LIHC	OS	Tertile	All	0.093	0.783	<.001	90	view →
SKCM	OS	Tertile	II,III,IV	0.174	0.731	<.001	42	view →
COAD	OS	Tertile	All	0.116	0.666	.027	36	view →
KIRC	DFS	Tertile	III,IV	0.063	0.750	<.001	30	view →
BLCA	DFS	Tertile	All	0.159	0.625	.016	27	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	9	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

MIR548AP–OV (OS)

Open the OV breakdown →